Skip to content

Comparison of Topography Guided LASIK With WaveLight® EX500 to SMILE With Zeiss VisuMax

Comparison of Topography Guided LASIK With WaveLight® EX500 to SMILE With Zeiss VisuMax

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02987660
Enrollment
21
Registered
2016-12-09
Start date
2017-03-03
Completion date
2017-07-26
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Astigmatism, Myopia

Brief summary

The purpose of this study is to compare Topography Guided Laser In Situ Keratomileusis (LASIK) corneal surgery to Small Incision Lenticule Extraction (SMILE) corneal surgery for the treatment of myopia with astigmatism.

Interventions

Corneal surgery for refractive error correction

Refractive surgical procedure for the correction of myopia with or without astigmatism

As used for corneal stroma ablation (refractive error correction). The treatment is intended to last the subject's lifetime.

As used for lenticule creation/removal (refractive error correction). The treatment is intended to last the subject's lifetime.

Sponsors

Alcon, a Novartis Company
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects in Singapore must be 21 years of age or older and subjects in Korea must be upon completion of 19 years of age or older due to local regulations; * Able to comprehend and sign an informed consent form; * Willing and able to complete all postoperative visits; * Myopia requiring (a) refractive error correction of -0.5 to -8.0 D optical infinity adjusted manifest refraction sphere with (b) astigmatism correction of -0.75 to -5.0 D manifest refraction cylinder and (c) at least 0.75 D of corneal astigmatism. * Intended treatment targeted for emmetropia; * Preoperative best-corrected visual acuity (BCVA) of 0 logMAR or better; * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Pregnant or lactating, current or planned, during the course of the study; * Dry eye; * Corneal disease; * Diagnosis of advanced glaucoma; * Uncontrolled diabetes; * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Eyes With Manifest Refraction Cylinder Less Than or Equal to 0.5 Diopter (D) at 3 MonthsMonth 3Manifest refraction cylinder was measured monocularly (each eye separately) at 3 or 4 meters (m) under photopic lighting conditions using a phoropter and Early Treatment Diabetic Retinopathy Study (ETDRS) chart. The manifest refraction at 4 m or 3 m was adjusted for optical infinity by adding -0.25 D to the sphere value. Both eyes contributed to the analysis. Since the study was terminated early, inferential statistics could not be completed.

Secondary

MeasureTime frameDescription
Mean Manifest Refraction Cylinder at 3 MonthsMonth 3Manifest refraction cylinder was measured monocularly at 3 or 4 meters under photopic lighting conditions using a phoropter and ETDRS chart. The manifest refraction at 4 m or 3 m was adjusted for optical infinity by adding -0.25 D to the sphere value. Both eyes contributed to the analysis. Since the study was terminated early, inferential statistics could not be completed.
Mean Uncorrected Visual Acuity (UCVA) at 3 MonthsMonth 3Uncorrected (without spectacles or other visual corrective devices) Visual Acuity (UCVA) testing was conducted monocularly in photopic conditions without glare at 3 or 4 meters. Visual Acuity (VA) is measured in logarithm of the minimum angle of resolution (logMAR). A lower logMAR value indicates better visual acuity. The Precision Vision illuminator cabinets and ETDRS charts were used. For subjects who could not read English letters, a numerical, Tumbling E logMAR chart was used. Since the study was terminated early, inferential statistics could not be completed.

Countries

France

Participant flow

Recruitment details

Subjects were recruited from 1 study center located in France.

Pre-assignment details

Of the 21 enrolled, 1 subject was exited as a screen failure prior to randomization. This reporting group includes all randomized subjects (20).

Participants by arm

ArmCount
LASIK
Topography Guided LASIK with WaveLight EX500 excimer laser system in bilateral surgery
10
SMILE
Small incision lenticular extraction (SMILE) with VisuMax laser in bilateral surgery
10
Total20

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyStudy terminated by sponsor1010

Baseline characteristics

CharacteristicLASIKSMILETotal
Age, Customized
< 65 years
10 Participants10 Participants20 Participants
Age, Customized
≥ 65 years
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants0 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
3 Participants5 Participants8 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
6 Participants5 Participants11 Participants
Sex: Female, Male
Female
7 Participants6 Participants13 Participants
Sex: Female, Male
Male
3 Participants4 Participants7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 10
other
Total, other adverse events
0 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

Percentage of Eyes With Manifest Refraction Cylinder Less Than or Equal to 0.5 Diopter (D) at 3 Months

Manifest refraction cylinder was measured monocularly (each eye separately) at 3 or 4 meters (m) under photopic lighting conditions using a phoropter and Early Treatment Diabetic Retinopathy Study (ETDRS) chart. The manifest refraction at 4 m or 3 m was adjusted for optical infinity by adding -0.25 D to the sphere value. Both eyes contributed to the analysis. Since the study was terminated early, inferential statistics could not be completed.

Time frame: Month 3

Population: ITT with non-missing data

ArmMeasureValue (NUMBER)
LASIKPercentage of Eyes With Manifest Refraction Cylinder Less Than or Equal to 0.5 Diopter (D) at 3 Months60 percentage of eyes
SMILEPercentage of Eyes With Manifest Refraction Cylinder Less Than or Equal to 0.5 Diopter (D) at 3 Months100.0 percentage of eyes
Secondary

Mean Manifest Refraction Cylinder at 3 Months

Manifest refraction cylinder was measured monocularly at 3 or 4 meters under photopic lighting conditions using a phoropter and ETDRS chart. The manifest refraction at 4 m or 3 m was adjusted for optical infinity by adding -0.25 D to the sphere value. Both eyes contributed to the analysis. Since the study was terminated early, inferential statistics could not be completed.

Time frame: Month 3

Population: ITT with non-missing data

ArmMeasureValue (MEAN)Dispersion
LASIKMean Manifest Refraction Cylinder at 3 Months-0.575 DioptersStandard Deviation 0.4091
SMILEMean Manifest Refraction Cylinder at 3 Months-0.232 DioptersStandard Deviation 0.1539
Secondary

Mean Uncorrected Visual Acuity (UCVA) at 3 Months

Uncorrected (without spectacles or other visual corrective devices) Visual Acuity (UCVA) testing was conducted monocularly in photopic conditions without glare at 3 or 4 meters. Visual Acuity (VA) is measured in logarithm of the minimum angle of resolution (logMAR). A lower logMAR value indicates better visual acuity. The Precision Vision illuminator cabinets and ETDRS charts were used. For subjects who could not read English letters, a numerical, Tumbling E logMAR chart was used. Since the study was terminated early, inferential statistics could not be completed.

Time frame: Month 3

Population: ITT with non-missing data

ArmMeasureValue (MEAN)Dispersion
LASIKMean Uncorrected Visual Acuity (UCVA) at 3 Months-0.100 logMARStandard Deviation 0.136
SMILEMean Uncorrected Visual Acuity (UCVA) at 3 Months-0.164 logMARStandard Deviation 0.0769

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026